Get App
Last Updated : Jan 07, 2020 10:09 AM IST | Source:

Granules India, Glenmark Pharma rally 3% on drug approvals from USFDA

Granules India got the nod for a painkiller, while Glenmark got it for Deferasirox tablets used in the treatment for chronic iron overload syndrome.

Representative image
Representative image
  • bselive
  • nselive
Todays L/H

Granules India and Glenmark Pharma share prices rallies nearly 3 percent in the morning trade on January 7 on receiving approvals from the US health regulator for new drugs.

Granules India, with a market capitalisation of Rs 3,100 crore, got the US Food and Drug Administration’s nod for Acetaminophen tablet, a painkiller.

Glenmark Pharma got the clearance for Deferasirox tablets, reported CNBC-TV18. Deferasirox is used in the treatment of chronic iron overload syndrome.

Granules India was quoting at Rs 123.65, up Rs 3.15, or 2.61 percent, and Glenmark was up Rs 7.35, or 2.16 percent, at Rs 347 on the BSE at 0947 hours.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jan 7, 2020 10:09 am
Follow us on